Welcome to LookChem.com Sign In|Join Free

CAS

  • or

20902-53-8

Post Buying Request

20902-53-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

20902-53-8 Usage

Description

(2S)-2,6-diaminohexanoic acid: 5-(dithiolan-3-yl)pentanoic acid is a compound consisting of two distinct components, (2S)-2,6-diaminohexanoic acid and 5-(dithiolan-3-yl)pentanoic acid. The former, also known as Lysine, is an essential amino acid crucial for protein synthesis and overall health, playing a vital role in the formation of collagen, muscles, and other tissues. The latter, 5-(dithiolan-3-yl)pentanoic acid, contains a dithiolane ring and is significant in biological processes, including the synthesis of coenzyme A. Together, these components form a unique compound with potential applications in various fields.

Uses

Used in Pharmaceutical Industry:
(2S)-2,6-diaminohexanoic acid: 5-(dithiolan-3-yl)pentanoic acid is used as a building block for the development of pharmaceutical compounds due to its unique structure and the properties of its constituent parts. The presence of Lysine and the dithiolane ring may contribute to the creation of new drugs with potential therapeutic effects.
Used in Nutritional Supplements:
(2S)-2,6-diaminohexanoic acid: 5-(dithiolan-3-yl)pentanoic acid can be utilized as a nutritional supplement to support overall health and well-being. The essential amino acid Lysine contributes to the maintenance of healthy tissues, while the dithiolane ring-containing component may aid in the synthesis of coenzyme A, which is vital for various metabolic processes.
Used in Cosmetics Industry:
Used in Research and Development:
The unique structure of (2S)-2,6-diaminohexanoic acid: 5-(dithiolan-3-yl)pentanoic acid makes it a valuable compound for research and development purposes. Scientists can explore its potential applications in various fields, such as drug discovery, nutritional science, and cosmetic formulation, to unlock new possibilities for health and wellness.

Check Digit Verification of cas no

The CAS Registry Mumber 20902-53-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,0,9,0 and 2 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 20902-53:
(7*2)+(6*0)+(5*9)+(4*0)+(3*2)+(2*5)+(1*3)=78
78 % 10 = 8
So 20902-53-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H14O2S2.C6H14N2O2/c9-8(10)4-2-1-3-7-5-6-11-12-7;7-4-2-1-3-5(8)6(9)10/h7H,1-6H2,(H,9,10);5H,1-4,7-8H2,(H,9,10)/t;5-/m.0/s1

20902-53-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S)-2,6-diaminohexanoic acid: 5-(dithiolan-3-yl)pentanoic acid

1.2 Other means of identification

Product number -
Other names lipoyllysine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:20902-53-8 SDS

20902-53-8Downstream Products

20902-53-8Relevant articles and documents

COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES AND CANCER

-

Paragraph 00118, (2020/01/11)

The invention relates to the compounds or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula II formula III, formula IV, formula V, formula VI, formula VII, and formula VIII and the methods for the treatment of inflammatory skin diseases and cancer may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, nasal spray, oral solution, suspension, oral spray, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treatment of facial hirsutism, GI Polyps, rosacea, acne, melanoma, psoriasis, dermatitis and cancer including gliomas, gastrointestinal polyps, anaplastic astrocytoma and metastatic cancers.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 20902-53-8